Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1983-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0022-3565(25)33479-8PMID 6296358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine.

  1982cited by this paper
• Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation.

  1982cited by this paper
• Enkephalin-like character and analgesia.

  1981cited by this paper
• The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone.

  1981cited by this paper
• Entry of opioid peptides into the central nervous system.

  1980cited by this paper
• A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.

  1980cited by this paper
• Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.

  1980cited by this paper
• Effect of morphine and naloxone on intestinal transit in mice.

  1980cited by this paper
• Centrally and peripherally mediated inhibition of intestinal motility by opioids

  1979cited by this paper
• Opiate receptors and opioid peptides.

  1979cited by this paper
• Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides.

  1979cited by this paper
• Central and peripheral actions of morphine on intestinal transit.

  1978cited by this paper
• beta-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates.

  1978cited by this paper
• Endogenous opioid peptides: multiple agonists and receptors

  1977cited by this paper
• Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone.

  1977cited by this paper
• Tolerance to the Effect of Morphine on Intestinal Transit 1

  1977cited by this paper
• Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.

  1977cited by this paper
• Development of tolerance to the stimulatory effect of morphine in dog intestine.

  1974cited by this paper
• Quantitative studies of the antagonism of morphine by nalorphine and naloxone.

  1969cited by this paper
• Further Evidence for an Unique Neurohumoral Agent Released from Brain by Morphine Given Intracerebrally

  1968cited by this paper
• A NEUROHUMORAL SUBSTANCE DISCHARGED INTO BLOOD PERFUSATE FROM ISOLATED RABBIT HEADS BY INTRACEREBRAL MORPHINE.

  1965cited by this paper
• Centrally Mediated Inhibition of Gastrointestinal Propulsive Motility By Morphine over a Non-Neural Pathway

  1963cited by this paper
• Comparative effects of analgesics on pain threshold, respiratory frequency and gastrointestinal propulsion.

  1959cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper

• Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak

  2020cites this paper
• Leites A1 e A2: revisão sobre seus potenciais efeitos no trato digestório

  2019cites this paper
• Milk Intolerance, Beta-Casein and Lactose

  2015cites this paper
• Neural and Endocrine Peptides and Receptors

  2012cites this paper
• Wirkungen und Nebenwirkungen der Opioide

  2010cites this paper
• Neurophysiologische Grundlagen chronischer Schmerzen

  2010cites this paper
• Hinterhorn des Rückenmarks — Ort der Modulation nozizeptiver Afferenzen

  2010cites this paper
• Opioide im Rahmen der Allgemeinanästhesie

  2010cites this paper
• Opioide in der Intensivmedizin

  2010cites this paper
• Postoperativer Einsatz von Opioiden

  2010cites this paper
• Rationale zur Opioidtherapie bei Schmerzen

  2010cites this paper
• Opioidwirkung abhängig von Affinität, intrinsischer Aktivität und Lipophilie

  2010cites this paper
• Opioidantagonisten gemischtwirkende Agonisten/ Antagonisten und partielle Agonisten

  2010cites this paper
• Der Schmerz als Teil des protektiven Systems

  2010cites this paper
• Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.

  2009cites this paper
• Chronic prevention of μ-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food

  2006cites this paper
• Spezielle, alternative Applikationsformen der Opioide

  2004cites this paper
• Schmerz und Opioide bei Kindern und Neugeborenen

  2004cites this paper
• Central effect of mu-opioid agonists on antral motility in conscious rats.

  2004cites this paper
• Pharmakokinetik der Opioide: Bedeutung für den praktischen Einsatz

  2004cites this paper
• Einsatz der Opioide bei alten Patienten

  2004cites this paper
• Neuroaxialer, rückenmarknaher Einsatz von Opioiden

  2002cites this paper
• Sucht- und Abhängigkeitspotential der Opioide

  2002cites this paper
• Opioide und Nausea — Emesis

  2002cites this paper
• Antitussive Wirkung der Opioide

  2002cites this paper
• Rezeptorinteraktion von Agonisten, Antagonisten und partiellen Agonisten

  2002cites this paper
• Opioide in der Langzeittherapie chronischer Schmerzen

  2002cites this paper
• Supraspinale Schmerzleitung und Schmerzverarbeitung

  2002cites this paper
• Opioide und gastrointestinale Hemmung (Obstipation)

  2002cites this paper
• Opioide und kardiovaskuläre Wirkungen

  2002cites this paper
• Opioide und Muskelstarre (Rigidität)

  2002cites this paper
• Opioide mit peripherem Angriffsort

  2002cites this paper
• Dose-related Effects of Controlled Release Dihydrocodeine on Oro-Cecal Transit and Pupillary Light Reflex

  2001cites this paper
• Gastric effects of methylnaltrexone on μ, κ and δ opioid agonists induced brainstem unitary responses

  1999cites this paper
• Neurophysiologische Grundlagen des Schmerzes

  1999cites this paper
• Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.

  1999cites this paper
• MORPHINE AND APOMORPHINE INHIBIT GASTROINTESTINAL TRANSIT (GIT) THROUGH TWO DIFFERENT MECHANISMS

  1999cites this paper
• Interaktionen der Opioide mit anderen Pharmaka

  1999cites this paper
• Dietary History Affects the Potency of Chronic Opioid Receptor Subtype Antagonist Effects upon Body Weight in Rats.

  1998cites this paper
• Gastric effects of μ-, δ- and κ-opioid receptor agonists on brainstem unitary responses in the neonatal rat

  1996cites this paper
• Die obstipierende Wirkung der Opioide Tilidin-N und Tramadol im Vergleich zu Codein

  1996cites this paper
• [Constipation after tilidine/naloxone and tramadol in comparison to codeine. A dose response study in human volunteers].

  1996cites this paper
• Allgemeine Kinetik zentraler Schmerzmittel — mit besonderer Berücksichtigung der Opioide

  1996cites this paper
• Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.

  1996cites this paper
• Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation.

  1995cites this paper
• Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.

  1995cites this paper
• Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.

  1995cites this paper
• Review article: anti‐diarrhoeal pharmacology and therapeutics

  1995cites this paper
• Effect of selective mu 1, mu 2 and delta 2 opioid receptor agonists on gastric functions in the rat.

  1994cites this paper
• Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channels.

  1994cites this paper
• Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity.

  1994cites this paper
• Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat.

  1994cites this paper
• Postoperative Epidural Opioids

  1993cites this paper
• Antidiarrheal and colonic antipropulsive effects of spinal and supraspinal administration of the natural delta opioid receptor agonist, [D-Ala2]deltorphin II, in the rat.

  1992cites this paper
• Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception

  1991cites this paper
• Opioid receptors and their ligands: natural and unnatural.

  1991cites this paper
• Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice.

  1991cites this paper
• Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution.

  1991cites this paper
• Pharmacological characterization of nalorphine, a kappa 3 analgesic.

  1991cites this paper
• Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.

  1991cites this paper
• Analgesie mit Opioiden bei Unfallverletzten

  1991cites this paper
• Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actions

  1991cites this paper
• Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions.

  1991cites this paper
• Autoradiographic study of irreversible binding of [3H]β-funaltrexamine to opioid receptors in the rat forebrain : comparison with μ and δ receptor distribution

  1991cites this paper
• Peptides: chemistry, biology, and pharmacology.

  1990cites this paper
• Central nervous system action of peptides to influence gastrointestinal motor function.

  1990cites this paper
• Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.

  1990cites this paper
• Naloxone benzoylhydrazone (NalBzoH) analgesia.

  1990cites this paper
• Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.

  1990cites this paper
• Effects of beta-casomorphin derivatives on gastrointestinal transit in mice.

  1990cites this paper
• Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents.

  1990cites this paper
• Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.

  1990cites this paper
• Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.

  1989cites this paper
• Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model.

  1989cites this paper
• Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.

  1989cites this paper
• Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.

  1989cites this paper
• Pharmacology of neuroendocrine peptides

  1989cites this paper
• Opioid Peptides of The Gut

  1989cites this paper
• Central Control of Gastrointestinal Transit and Motility by Brain—Gut Peptides

  1989cites this paper
• Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat.

  1989cites this paper
• Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.

  1989cites this paper
• Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.

  1989cites this paper
• Regulation of gastrointestinal function by multiple opioid receptors.

  1988cites this paper
• Central mu, delta- and kappa-opioid influences on intestinal water and electrolyte transport in dogs.

  1988cites this paper
• Antinociceptive effects of the novel opioid peptide BW443C compared with classical opiates; peripheral versus central actions

  1988cites this paper
• Central μ-, δ- and κ-opioid influences on intestinal water and electrolyte transport in dogs

  1988cites this paper
• [The agonist-antagonist nalbuphine prolongs gastro-cecal transit time and induces short-term pain following neuroleptanesthesia using fentanyl. A comparative study using a placebo].

  1988cites this paper
• Differential blockade by naloxonazine of two mu opiate actions: analgesia and inhibition of gastrointestinal transit.

  1988cites this paper
• Supraspinal cerebral areas involved in morphine's intestinal inhibition and analgesia.

  1988cites this paper
• Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.

  1987cites this paper
• Naloxonazine and opioid-induced inhibition of reflex urinary bladder contractions.

  1987cites this paper
• Peptide opioid antagonist separates peripheral and central opioid antitransit effects.

  1987cites this paper
• Colonic bead expulsion time in normal and μ-opioid receptor deficient (CXBK) mice following central (ICV) administration of μ- and δ-opioid agonists

  1987cites this paper
• Methods used for the study of opioid receptors.

  1987cites this paper
• Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.

  1987cites this paper
• Colonic bead expulsion time in normal and mu-opioid receptor deficient (CXBK) mice following central (ICV) administration of mu- and delta-opioid agonists.

  1987cites this paper
• Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.

  1986cites this paper
• Central opioid receptor involvement in gastrointestinal motility

  1986cites this paper
• Conformationally Restricted Cyclic Penicillamine Analogues with High Selectivity for δ- and μ-Opioid Receptors

  1986cites this paper
• Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.

  1986cites this paper